RSS   Newsletter   Contact   Advertise with us

Audentes Therapeutics appoints Jennifer Jarrett to board

Share on Twitter Share on LinkedIn
Staff Writer | San Francisco, Ca., USA | June 14, 2017
Audentes TherapeuticsJune 14, 2017, San Francisco, Ca., USA - Audentes Therapeutics, a biotechnology company, announced the appointment of Jennifer Jarrett to its board of directors.
Ms. Jarrett serves as the Chief Financial and Business Officer of Arcus Biosciences, Inc.

Ms. Jarrett served as Chief Financial Officer of Medivation, Inc. until the company's purchase by Pfizer, Inc. in 2016.

Previously, she served as Managing Director at Citigroup, where she was responsible for building and managing Citigroup's West Coast life sciences investment banking practice.

Prior to Citigroup, Ms. Jarrett was a Managing Director in Credit Suisse's Health Care Group focused on the biotechnology sector.

She earned a bachelor's degree in economics, Cum Laude, from Dartmouth College and holds a masters of business administration from Stanford Graduate School of Business.